T L Delovitch
Overview
Explore the profile of T L Delovitch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Blumenfeld H, Tohn R, Haeryfar S, Liu Y, Savage P, Delovitch T
Clin Exp Immunol
. 2011 Sep;
166(1):121-33.
PMID: 21910729
Because invariant natural killer T (iNK T) cells link innate and adaptive immunity, the structure-dependent design of iNK T cell agonists may have therapeutic value as vaccines for many indications,...
3.
Tohn R, Blumenfeld H, Haeryfar S, Veerapen N, Besra G, Porcelli S, et al.
Clin Exp Immunol
. 2011 Mar;
164(1):26-41.
PMID: 21361909
We have reported previously that treatment of non-obese diabetic (NOD) mice with the invariant natural killer T (iNK T) cell agonist α-galactosylceramide C26:0 (α-GalCer) or its T helper type 2...
4.
Rowden G, Phillips T, Delovitch T
Immunogenetics
. 2011 Feb;
7(1):465-78.
PMID: 21302100
Immunofluorescent and immunoelectron-microscopic staining methods were utilized to investigate the localization of Ia antigens in murine keratinizing epithelia. Approximately 3-5% of epidermal cells were shown to be Ia positive. Only...
5.
Ly D, Tohn R, Rubin B, Blumenfeld H, Besra G, Veerapen N, et al.
Clin Exp Immunol
. 2009 Dec;
160(2):185-98.
PMID: 20015094
Protection from type 1 diabetes (T1D), a T helper type 1 (Th1)-mediated disease, is achievable in non-obese diabetic (NOD) mice by treatment with alpha-galactosylceramide (alpha-GalCer) glycolipids that stimulate CD1d-restricted invariant...
6.
Wang S, Diao H, Guan Q, Cruikshank W, Delovitch T, Jevnikar A, et al.
Kidney Int
. 2007 Nov;
73(3):318-26.
PMID: 18004294
T-cell-mediated renal injury is a major cause of kidney transplant rejection and renal failure; hence, understanding T-cell migration within the kidney is important for preventing renal injury. Interleukin (IL)-16 is...
7.
Meagher C, Sharif S, Hussain S, Cameron M, Arreaza G, Delovitch T
Adv Exp Med Biol
. 2003 Mar;
520:133-58.
PMID: 12613577
No abstract available.
8.
Chen W, Bergerot I, Elliott J, Harrison L, Abiru N, Eisenbarth G, et al.
J Immunol
. 2001 Oct;
167(9):4926-35.
PMID: 11673498
The expression of pro(insulin) in the thymus may lead to the negative selection of pro(insulin) autoreactive T cells and peripheral tolerance to this autoantigen in type 1 diabetes (T1D). We...
9.
Sharif S, Delovitch T
Arch Immunol Ther Exp (Warsz)
. 2001 Oct;
49 Suppl 1:S23-31.
PMID: 11603866
Natural killer T (NKT) cells, which comprise a minor population of T cells in primary and secondary lymphoid organs, possess phenotypic characteristics of both NK and T cells. NKT cells...
10.
Arreaza G, Sharif S, Cameron M, Chen W, Delovitch T
Curr Dir Autoimmun
. 2001 Sep;
4:308-32.
PMID: 11569408
No abstract available.